The Medical Imaging & Technology Alliance (MITA) recently applauded Congress for passing another two-year suspension of the medical device excise tax.
“MITA is pleased with the passage of the two-year suspension of the medical device tax, as it ensures that our companies are able to continue investing in innovative technologies to improve patient care,” says Joe Robinson, chairman of the MITA board of directors and senior vice president of health systems solutions at Philips Healthcare. “We are encouraged by the bipartisan support in Congress and hope that policymakers will continue their work toward a long-term solution to the tax.”
The House joined the Senate in passing the bill to suspend the medical device tax. It passed 81-18 in the Senate and 266-150 in the House.
The 2.3 percent medical device excise tax was levied on the sale of medical devices that are fundamental to the practice of medicine both in diagnosing and treating disease. In 2015, a bipartisan coalition in the House and Senate approved a two-year suspension of the tax, which expired in December.
